Prostate cancer; the interface between pathology and basic scientific research

Seminars in Cancer Biology

Volumn 8, Issue 1, 1997, Pages 53-59

  Lalani, E N ^a   Stubbs, A ^a   Stamp, G W H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Grading; Histopathology; Molecular pathology; Prostate cancer

Indexed keywords

DNA; MESSENGER RNA;

ALLELE; ANIMAL MODEL; CANCER GRADING; CANCER GROWTH; CANCER RESEARCH; CANCER STAGING; COCULTURE; EXPERIMENTAL MODEL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OBSERVER VARIATION; PATHOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE DISTRIBUTION; TISSUE FIXATION; TRANSGENIC MOUSE; TUMOR BIOPSY;

EID: 0031078368     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1997.0052     Document Type: Article

References (29)

1. 1. Woolf SH (1995) Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. [Review]. N EnglJ Med 333:1401-1405
2. 2. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. Cancer J Clin 46:5-27
3. 3. Schroder FH, Boyle P (1993) Screening for prostate cancer -necessity or nonsense? [Review]. Eur J Cancer 29A: 656-661
4. 4. Potosky AL, Miller BA, Albertsen PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548-552
5. 5. Hall RR (1996) Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against. Eur Urol 29 (Suppl 2); 24-26
6. 6. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK (1993) Prostate cancer screening: what we know and what we need to know. Ann Int Med 119:948-949
7. 7. Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ (1996) Prospective characterization of pathological features of prostatic carcinomas detected in a seruna prostate specific antigen based screening. J, Urol, 155: 816-820
8. 8. Schroder FH (1995) Detection of prostate cancer [editorial] [see comments]. Br Med J 310:140-141
9. 9. Boyle P, Maisonneuve P, Napalkov P (1996) Incidence of prostate cancer will double by the year 2030: the argument for. Eur Urol 29 (Suppl 2): 3-9
10. 10. Bostwick DG (1996) Progression of prostate intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30:145-152
11. 11. Epstein JL, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, Wheeler TM (1995) Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 19:873-886
12. 12. Algaba F, Trias I (1996) Diagnostic limits in precursor lesions of prostatic cancer. Eur Urol 30:212-221
13. 13. Rauiv G, Janssen T, Zlotta AR (1996), Descamps F, Verhast A, Schulman CC (1996), Prostatic intraepithelial neoplasia. Influence of clinical and pathalogical data on the detection of prostate cancer. J Urol, 156: 1050-1055
14. 14. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD (1996) Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 30:138-144
15. 15. Bostwick DG, Dundore PA (1997) Variants of prostatic adenocarcinoma, in Biopsy Pathology of the Prostate, pp 167-190. Chapman and Hall Medical, London
16. 16. di Sant' Agnes PA (1996) Neuroendocrine differentiation in the precursors of prostate cancer. Eur Urol 30:185-190
17. 17. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23:273-279
18. 18. Gardner WA, Jr, Coffey D, Karr JP (1998) A uniform histopathologic grading system for prostatic cancer. Hum Pathol 19:119-120
19. 19. Aihara M, Wheelar TM, Oliori M, Scardino PT (1994) Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 43:60-66
20. 20. Schroder FH, Hop WCJ, Blom JH, et al (1985) Grading of prostate cancer: Multivariate analysis of prognostic parameters. Prostate 7:13-20
21. 21. Schaeffer J, Tegeler JA, Kubran DA, et al (1992) Nuclear roundness factor and local failure from definitive radiation therapy for prostate carcinoma. Int J Rad Biol Phys 24:431-434
22. 22. Berthon P, Dimitrov T, Stower M, Cussenot O, Maitland NJ (1995) A microdissection approach to detect molecular markers during progression of prostate cancer. Br J Cancer 72:946-951
23. 23. Stamp GWH, Pulsom R (1991) In situ hybridisation in pathology - techniques and applications. Surgery 202-203
24. 24. Negus RP, Stamp GWH, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391-2396
25. 25. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L, Stamp GWH (1992) Stromal expression of 72kDa Type IV collagenase (MMP-2) and TIMP 2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396
26. 26. Morrison L, Legator M (1993) Multicolor in situ hybridisation using direct labelled fluorescent probes. Clin Chem 39:733-734
27. 27. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB (1994) Aneuploidy and aneusomy of chromosome 7 detected by fluorescent in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002
28. 28. Stamp GWH, Fantl V, Poulsom R, Dickson C, Peters G (1992) Non-uniform expression of a mouse mammary tumor virus driven int-2/ Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Diff 3:929-938
29. 29. Williams R, Stamp GWH, Pignatelli M, Lalani E-N (1996) pS2 transfection of murine adenocarcinoma cell line (410.4) enhances dispersed growth pattern in 3-D collagen gel. J Cell Sci 109:63-71